Droloxifene
Alternative Names: 3 OH TAM; Droloxifene citrate; FK 435; K 060; K 21060E; RP 60850Latest Information Update: 25 Jan 2000
Price :
$50 *
At a glance
- Originator Klinge Pharma
- Developer Klinge Pharma; Ligand Pharmaceuticals; Pfizer
- Class Antineoplastics; Osteoporosis therapies; Stilbenes
- Mechanism of Action Selective estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Breast cancer; Cardiovascular disorders; Male osteoporosis; Postmenopausal osteoporosis
Most Recent Events
- 25 Jan 2000 Discontinued-II for Breast cancer prevention in USA (PO)
- 25 Jan 2000 Discontinued-II for Cardiovascular disorders in USA (PO)
- 25 Jan 2000 Discontinued-II for Male osteoporosis in USA (PO)